Invention Grant
- Patent Title: Sustained-release buprenorphine solutions
-
Application No.: US15125052Application Date: 2015-03-09
-
Publication No.: US10022367B2Publication Date: 2018-07-17
- Inventor: Mingxing Zhou , Richard L. Norton
- Applicant: Indivior UK Limited
- Applicant Address: GB Slough
- Assignee: Indivior UK Limited
- Current Assignee: Indivior UK Limited
- Current Assignee Address: GB Slough
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Priority: GB1404139.6 20140310
- International Application: PCT/GB2015/050676 WO 20150309
- International Announcement: WO2015/136253 WO 20150917
- Main IPC: A61K9/08
- IPC: A61K9/08 ; A61K9/00 ; A61K31/485 ; A61K47/10 ; A61K47/22
Abstract:
The disclosure provides extended release pharmaceutical formulations comprising an opioid, particularly buprenorphine, a biocompatible organic solvent, and, optionally, a glycol, for use in the treatment of pain or opioid dependence. The pharmaceutical formulations are in the form of a pharmaceutical solution.
Public/Granted literature
- US20170079974A1 SUSTAINED-RELEASE BUPRENORPHINE SOLUTIONS Public/Granted day:2017-03-23
Information query
